Clinical trial · Interventional
Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors
Diagnostic Assessment Study, Single Site and Prospective, comparing18F-DOPA PET and Multiparametric RMI in Initial Exploration of Diffuse Glial Tumors
NCT03525080CI-TRIAL-00043018GLIROPAcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
For patient having a brain tumor, RMI is the standard exam for tumor characterization and determines initial surgery. The aim of this study is to assess if PET could provide additional information that could have an impact on surgery (indication and planification)
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult Brain Tumor | Adult Brain Neoplasm | ALIAS | 0.90 |
| Brain Neoplasms | Brain Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET imagery | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- PET Arm
- interventionNames
- Diagnostic Test: PET imagery
Primary outcomes (1)
- measure
- PET pictures and MRI sequences comparison
- timeFrame
- Imagings performed up to 29 days after inclusion (before brain surgery)
- description
- Comparison of PET pictures and MRI sequences will be done in order to assess concordance between both imagings
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Suspected glial resectable tumor * Free and informed consent * Affiliated to French social security Exclusion Criteria: * Suspected high grade glioma * Surgical emergency * Pregnant or breastfeeding woman * Patient deprived of their liberty or under guardianship * Patient not able to follow study medical monitoring for geographical, social or psychological reasons * Treated with carbidopa, catechol-O-methyl transferase inhibitor, haloperidol, reserpine within 2 weeks before PET imagery
References
Publications (0)
Data not yet available
No reference posted for this study.